FEB 08, 2020 9:11 PM PST

Drug Targets Brain-Eating Amoebas

WRITTEN BY: Nouran Amin

Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfortunately, there has not been any effective drug that is available to fight off these infections. Now, scientists are bringing renewed hope by designing promising compounds for future treatments—findings were published in ACS Chemical Neuroscience.

Learn more about brain-eating amoebas:

The two types of amoebae species--Naegleria fowleri and Balamuthia mandrillaris—cause the primary amoebic brain infections. Amoebaes are single-celled microorganisms that survive in water and soil and can enter the body via the nose or open wounds. These pathogenic creatures move to the central nervous system to eradicate brain cells. Only in small cases due antimicrobial treatments given in high doses successfully evade toxifying a patient. Now, researchers have turned into quinazolinones drugs that may offer an alternate pathway. These drugs are known to be effective against a wide spectrum of pathogens including bacteria, viruses, fungi and parasites. However, they have never been tested on brain-eating amoebae.

In the study, researchers synthesized 34 new quinazolinone compounds and they studied their effects on N. fowleri and B. mandrillaris. Some of the compounds were effective at killing the microorganisms and limiting the danger they can cause to human cells in a Petri dish. Some of the compounds when attached to silver nanoparticles to the derivatives enhanced their activity. The most effective drugs contained chlorine, methyl or methoxy groups, and their toxicity was low in human cells. Results conclude that quinazolinones are good drug candidates for future therapeutic studies.

Source: American Chemical Society

 

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAR 06, 2021
Genetics & Genomics
Green Tea Extract Can Affect Facial Development in Kids With Down Syndrome
MAR 06, 2021
Green Tea Extract Can Affect Facial Development in Kids With Down Syndrome
Individuals with Down syndrome often have certain facial features. New research has suggested that green tea supplements ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
APR 24, 2021
Drug Discovery & Development
Lithium Treats Intellectual Disabilities in Mice
APR 24, 2021
Lithium Treats Intellectual Disabilities in Mice
Mouse models of Bardet-Biedl Syndrome (BBS) have a challenge with learning as a result of dysfunctional neuronal systems ...
MAY 06, 2021
Drug Discovery & Development
Tweaked Version of Ketamine Could Solve the Opioid Crisis
MAY 06, 2021
Tweaked Version of Ketamine Could Solve the Opioid Crisis
Medications that manage post-operative pain are some of the main entry points to opioid addiction and overdose in the US ...
MAY 06, 2021
Cannabis Sciences
New CBD Analog Outperforms Regular CBD for Pain Relief
MAY 06, 2021
New CBD Analog Outperforms Regular CBD for Pain Relief
Researchers from Temple University Health System have found that a novel cannabidiol (CBD) analog can reverse pain sensi ...
JUN 02, 2021
Cannabis Sciences
Can CBD Help Manage Symptoms of Diabetes?
JUN 02, 2021
Can CBD Help Manage Symptoms of Diabetes?
As cannabidiol (CBD) products become increasingly mainstream, more people are using them to manage symptoms for chronic ...
Loading Comments...